Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Endocannabinoid Signaling System in the CNS
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran, Tom P. Freeman, Claire Mokrysz, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 5, pp. 293-306
Open Access | Times Cited: 360
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 155-172
Open Access | Times Cited: 360
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 176
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior
Henrietta Szutorisz, Yasmin L. Hurd
Neuroscience & Biobehavioral Reviews (2017) Vol. 85, pp. 93-101
Open Access | Times Cited: 124
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels
Angelique G. Brellenthin, Kevin M. Crombie, Cecilia J. Hillard, et al.
Medicine & Science in Sports & Exercise (2017) Vol. 49, Iss. 8, pp. 1688-1696
Closed Access | Times Cited: 108
Endocannabinoid Signaling and the Hypothalamic‐Pituitary‐Adrenal Axis
Cecilia J. Hillard, Margaret Beatka, Jenna Sarvaideo
Comprehensive physiology (2016), pp. 1-15
Open Access | Times Cited: 88
Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort
Terri A. deRoon‐Cassini, Carisa Bergner, Samantha A. Chesney, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Diagnosis and Management of Cyclic Vomiting Syndrome: A Critical Review
Rosita Frazier, B U.K. Li, Thangam Venkatesan
The American Journal of Gastroenterology (2023) Vol. 118, Iss. 7, pp. 1157-1167
Closed Access | Times Cited: 22
Schisandra chinensis lignans exerts endocannabinoids-like antidepressive effect: the phagocytotic relationship of activated CB2R-mediated M2 microglia and “stressed-but-viable” neuron
Jinyu Wang, Haoyu Du, Mengru Li, et al.
Journal of Ethnopharmacology (2025), pp. 119385-119385
Closed Access | Times Cited: 1
Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ranjini Garani Ramesh, Jeremy J. Watts, Romina Mizrahi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110096-110096
Open Access | Times Cited: 51
Cannabis and cannabinoids: pharmacology and therapeutic potential
Małgorzata Śmiarowska, Monika Białecka, Anna Machoy‐Mokrzyńska
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 1, pp. 4-13
Open Access | Times Cited: 29
Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges
Faiz‐ul Hassan, Chunjie Liu, Maryam Mehboob, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Exploring causal mechanisms of psychosis risk
Dominic Oliver, Edward Chesney, Alexis E. Cullen, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105699-105699
Open Access | Times Cited: 6
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder
Kevin M. Crombie, Angelique G. Brellenthin, Cecilia J. Hillard, et al.
Journal of Traumatic Stress (2018) Vol. 31, Iss. 1, pp. 134-145
Closed Access | Times Cited: 54
Meet Your Stress Management Professionals: The Endocannabinoids
Terri A. deRoon‐Cassini, Todd M. Stollenwerk, Margaret Beatka, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 953-968
Open Access | Times Cited: 48
Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD
Kevin M. Crombie, Brianna N. Leitzelar, Angelique G. Brellenthin, et al.
Biological Psychology (2019) Vol. 145, pp. 1-7
Closed Access | Times Cited: 47
Cannabinoid signaling promotes the de‐differentiation and proliferation of Müller glia‐derived progenitor cells
Warren A. Campbell, S A Blum, Alana Reske, et al.
Glia (2021) Vol. 69, Iss. 10, pp. 2503-2521
Open Access | Times Cited: 35
Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions
Michael Siebers, Sarah V. Biedermann, Johannes Fuß
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 352-369
Open Access | Times Cited: 24
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Stefano Comai, Nicolás A. Núñez, Tobias Atkin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 4
Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy
Sina Pakkhesal, Mohammad Shakouri, Reza Mosaddeghi-Heris, et al.
Pharmacology & Therapeutics (2025), pp. 108799-108799
Closed Access
DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2)
Adam Worob, Cody J. Wenthur
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 23, pp. 3881-3892
Closed Access | Times Cited: 35
The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease
Smita Jain, Akansha Bisht, Kanika Verma, et al.
Cell Biochemistry and Function (2021) Vol. 40, Iss. 2, pp. 106-117
Closed Access | Times Cited: 29
Circulating endocannabinoids and psychological outcomes in women with PTSD
Chloe Botsford, Angelique G. Brellenthin, Josh M. Cisler, et al.
Journal of Anxiety Disorders (2022) Vol. 93, pp. 102656-102656
Open Access | Times Cited: 19
The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses
Matthew N. Hill, Margaret Haney, Cecilia J. Hillard, et al.
Psychological Medicine (2023) Vol. 53, Iss. 15, pp. 7006-7024
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top